Revolutionizing
women’s health
Empowering patients and healthcare professionals with intelligent drug delivery and health data.
The LiGalli MedRing
Introducing the first personalized vaginal drug delivery device
The LiGalli MedRing supports drug administration as desired. The right dose at the right time, up to 28 days.
While the device is in use, a programmable schedule takes care of the drug delivery, without the need for the user to remember – improving therapy compliance.
The vagina provides an excellent environment for drug intake and monitoring of bio signals.
The MedRing Platform

Device
MedRing
Designed to deliver drugs systemically via the vaginal wall and monitor bio signals.
Suitable for a range of drugs.

Smartphone
Companion App
Enable patients to schedule and monitor drug administration within predefined boundaries.

Cloud
Data Platform
Enables secure storage of collected health data and, with consent, share it with healthcare professionals.
LiGalli is founded by a dedicated team of professionals
with deep expertise in women’s health and medical devices.
We believe treatment for women requires significant improvement.
Our aim is to develop solutions that are
more precisely tailored to the unique needs of women.
At LiGalli we collaborate with the best-in-class industry experts,
ensuring that innovation is driven by both scientific excellence
and deep understanding of women’s health.
Get in touch
Office
Leiden Bio Science Park – BioPartner 1
Address
J.H. Oortweg 21
2333 CH Leiden
The Netherlands
Disclaimer policy
This website of LiGalli B.V., Leiden, The Netherlands, includes forward looking statements.
These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks, evolving uncertainties and change.
There can be no guarantees, with respect to pipeline products, that they will receive necessary regulatory approval nor that they will prove to be commercially successful.
If underlying assumptions might prove to be inaccurate, or risks or uncertainties materialize, actual situations and results may differ materially from those set forth in the forward looking statements in the LiGalli website.